Abstract

The vascular endothelial growth factor (VEGF) is produced by different types of cells and has a major role in both, physiological and pathological angiogenesis. On the one hand VEGF is a strong mitotic and chemotactic factor for the endothelial cells, stimulating thus formation of new vessels, while on the other, it enhances the vascular endothelium permeability of the existing blood vessels which contributes to development and persistence of the inflammatory conditions. In the latter its activity is by 50 000 times higher than that of histamine. VEGF facilitates formation of oedema and leukocyte migration from the circulation to the site of inflammation. VEGF is also important in remodeling of the extracellular matrix. Moreover, it has an important significance in regulation of the immunological response, therefore plays a role in autoaggressive phenomena as well as immediate- and delayed-type hypersensitivity. Its role in the pathogenesis of immunological and inflammatory diseases, including allergy, asthma and different skin disorders has been indicated.

References

• 1. Abdel-Majid R.M., Marshall J.S.: Prostaglandin E2 induces degranulation-independentproduction of vascular endothelial growth factorby human mast cells. J. Immunol., 2004; 172: 1227-1236 2 Abdel-Rahman A.M., el-Sahrigy S.A., Bakr S.I.: A comparativestudy of two angiogenic factors: vascular endothelial growth factorand angiogenin in induced sputum from asthmatic children inacute attack. Chest, 2006; 129: 266-271
  Google Scholar
• 2. J. Cell Sci., 2003; 116: 665-674
  Google Scholar
• 3. Barleon B., Reusch P., Totzke F., Herzog C., Keck C., Martiny-BaronG., Marmé D.: Soluble VEGFR-1 secreted by endothelial cells andmonocytes is present in human serum and plasma from healthydonors. Angiogenesis, 2001; 4: 143-154
  Google Scholar
• 4. Bernatchez P.N., Winstead M.V., Dennis E.A., Sirois M.G.: VEGFstimulation of endothelial cell PAF synthesis is mediated by groupV 14 kDa secretory phospholipase A2. Br. J. Pharmacol., 2001; 134:197-205
  Google Scholar
• 5. Boesiger J., Tsai M., Maurer M., Yamaguchi M., Brown L.F., ClaffeyK.P., Dvorak H.F., Galli S.J.: Mast cells can secrete vascular permeabilityfactor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulationof Fcε receptor I expression. J. Exp. Med., 1998; 188: 1135-1145
  Google Scholar
• 6. Boocock C.A., Charnock-Jones D.S., Sharkey A.M., McLaren J.,Barker P.J., Wright K.A., Twentyman P.R., Smith S.K.: Expression ofvascular endothelial growth factor and its receptors flt and KDR inovarian carcinoma. J. Natl. Cancer Inst., 1995; 87: 506-516
  Google Scholar
• 7. Brkovic A., Sirois M.G.: Vascular permeability induced by VEGFfamily members in vivo: role of endogenous PAF and NO synthesis.J. Cell. Biochem., 2007; 100: 727-737
  Google Scholar
• 8. Brown L.F., Harrist T.J., Yeo K.T., Stahle-Bäckdahl M., JackmanR.W., Berse B., Tognazzi K., Dvorak H.F., Detmar M.: Increased expressionof vascular permeability factor (vascular endothelial growthfactor) in bullous pemphigoid, dermatitis herpetiformis, and erythemamultiforme. J. Invest. Dermatol., 1995; 104: 744-749
  Google Scholar
• 9. Brown L.F., Olbricht S.M., Berse B., Jackman R.W., Matsueda G.,Tognazzi K.A., Manseau E.J., Dvorak H.F., Van de Water L.: Overexpressionof vascular permeability factor (VPF/VEGF) and its endothelialcell receptors in delayed hypersensitivity skin reactions. J.Immunol., 1995; 154: 2801-2807
  Google Scholar
• 10. Caine G.J., Lip G.Y., Stonelake P.S., Ryan P., Blann A.D.: Plateletactivation, coagulation and angiogenesis in breast and prostate carcinoma.Thromb. Haemost., 2004; 92: 185-190
  Google Scholar
• 11. Cao J., Cetrulo C.L., Theoharides T.C.: Corticotropin-releasinghormone induces vascular endothelial growth factor releasefrom human mast cells via the cAMP/protein kinase A/p38 mitogen-activatedprotein kinase pathway. Mol. Pharmacol., 2006;69: 998-1006
  Google Scholar
• 12. Cao J., Papadopoulou N., Kempuraj D., Boucher W.S., SugimotoK., Cetrulo C.L., Theoharides T.C.: Human mast cells express corticotropin-releasinghormone (CRH) receptors and CRH leads to selectivesecretion of vascular endothelial growth factor. J. Immunol.,2005; 174: 7665-7675
  Google Scholar
• 13. Cho M., Hunt T.K., Hussain M.Z.: Hydrogen peroxide stimulatesmacrophage vascular endothelial growth factor release. Am.J. Physiol. Heart Circ. Physiol., 2001; 280: H2357-H2363
  Google Scholar
• 14. Clauss M.: Molecular biology of the VEGF and the VEGF receptorfamily. Semin. Thromb. Hemost., 2000; 26: 561-569
  Google Scholar
• 15. Colman R.W.: Regulation of angiogenesis by the kallikrein-kininsystem. Curr. Pharm. Des., 2006; 12: 2599-2607
  Google Scholar
• 16. Cuadrado M.J., Buendia P., Velasco F., Aguirre M.A., BarbarrojaN., Torres L.A., Khamashta M., López-Pedrera C.: Vascular endothelialgrowth factor expression in monocytes from patients with primaryantiphospholipid syndrome. J. Thromb. Haemost., 2006; 4: 2461-2469
  Google Scholar
• 17. de Paulis A., Prevete N., Fiorentino I., Rossi F.W., Staibano S.,Montuori N., Ragno P., Longobardi A., Liccardo B., Genovese A., RibattiD., Walls A.F., Marone G.: Expression and functions of the vascularendothelial growth factors and their receptors in human basophils.J. Immunol., 2006; 177: 7322-7331
  Google Scholar
• 18. Detmar M., Brown L.F., Schön M.P., Elicker B.M., Velasco P., RichardL., Fukumura D., Monsky W., Claffey K.P., Jain R.K.: Increased microvasculardensity and enhanced leukocyte rolling and adhesion inthe skin of VEGF transgenic mice. J. Invest. Dermatol., 1998; 111: 1-6
  Google Scholar
• 19. Detmar M., Yeo K.T., Nagy J.A., Van de Water L., Brown L.F.,Berse B., Elicker B.M., Ledbetter S., Dvorak H.F.: Keratinocyte-derivedvascular permeability factor (vascular endothelial growth factor)is a potent mitogen for dermal microvascular endothelial cells. J.Invest. Dermatol., 1995; 105: 44-50
  Google Scholar
• 20. Devillers A.C., van Toorenenbergen A.W., Klein-HeerenbrinkG.J., Muldert P.G., Oranje A.P.: Elevated levels of plasma matrix metalloproteinase-9in patients with atopic dermatitis: a pilot study.Clin. Exp. Dermatol., 2007; 32: 311-313
  Google Scholar
• 21. Dvorak H.F., Detmar M., Claffey K.P., Nagy J.A., van de WaterL., Senger D.R.: Vascular permeability factor/vascular endothelialgrowth factor: an important mediator of angiogenesis in malignancyand inflammation. Int. Arch. Allergy Immunol., 1995; 107: 233-235
  Google Scholar
• 22. Esser S., Lampugnani M.G., Corada M., Dejana E., Risau W.: Vascularendothelial growth factor induces VE-cadherin tyrosine phosphorylationin endothelial cells. J. Cell Sci., 1998; 111: 1853-1865
  Google Scholar
• 23. Feistritzer C., Kaneider N.C., Sturn D.H., Mosheimer B.A., KählerC.M., Wiedermann C.J.: Expression and function of the vascular endothelialgrowth factor receptor FLT-1 in human eosinophils. Am.J. Respir. Cell Mol. Biol., 2004; 30: 729-735
  Google Scholar
• 24. Ferrara N., Davis-Smyth T.: The biology of vascular endothelialgrowth factor. Endocr. Rev., 1997; 18: 4-25
  Google Scholar
• 25. Ferrara N., Henzel W.J.: Pituitary follicular cells secrete a novelheparin-binding growth factor specific for vascular endothelial cells.Biochem. Biophys. Res. Commun., 1989; 161: 851-858
  Google Scholar
• 26. Ferrara N., Keyt B.: Vascular endothelial growth factor: basicbiology and clinical implications. EXS, 1997; 79: 209-232
  Google Scholar
• 27. Fink K., Boratyński J.: Rola metaloproteinaz w modyfikacji macierzyzewnątrzkomórkowej w nowotworowym wzroście inwazyjnym,w przerzutowaniu i w angiogenezie. Postępy Hig. Med. Dośw.,2012; 66: 609-628
  Google Scholar
• 28. Fong G.H., Rossant J., Gertenstein M., Breitman M.L.: Role of theFlt-1 receptor tyrosine kinase in regulating the assembly of vascularendothelium. Nature, 1995; 376: 66-70
  Google Scholar
• 29. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., KoosR.D., Semenza G.L.: Activation of vascular endothelial growth factorgene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol.,1996; 16: 4604-4613
  Google Scholar
• 30. Frank S., Hübner G., Breier G., Longaker M.T., Greenhalgh D.G.,Werner S.: Regulation of vascular endothelial growth factor expressionin cultured keratinocytes. Implications for normal and impairedwound healing. J. Biol. Chem., 1995; 270: 12607-12613
  Google Scholar
• 31. Ghosh A.K.: Regulation by prostaglandin E2 and histamine ofangiogenesis in inflammatory granulation tissue. Yakugaku Zasshi,2003; 123: 295-303
  Google Scholar
• 32. Gille J., Swerlick R.A., Caughman S.W.: Transforming growthfactor-α-induced transcriptional activation of the vascular permeabilityfactor (VPF/VEGF) gene requires AP-2-dependent DNA bindingand transactivation. EMBO J., 1997; 16: 750-759
  Google Scholar
• 33. Griga T., Gutzeit A., Sommerkamp C., May B.: Increased productionof vascular endothelial growth factor by peripheral bloodmononuclear cells in patients with inflammatory bowel disease. Eur.J. Gastroenterol. Hepatol., 1999; 11: 175-179
  Google Scholar
• 34. Grützkau A., Krüger-Krasagakes S., Baumeister H., SchwarzC., Kögel H., Welker P., Lippert U., Henz B.M., Möller A.: Synthesis,storage, and release of vascular endothelial growth factor/vascularpermeability factor (VEGF/VPF) by human mast cells: implicationsfor the biological significance of VEGF206. Mol. Biol. Cell,1998; 9: 875-884
  Google Scholar
• 35. Harmey J.H., Dimitriadis E., Kay E., Redmond H.P., BouchierHayesD.: Regulation of macrophage production of vascular endothelialgrowth factor (VEGF) by hypoxia and transforming growthfactor β-1. Ann. Surg. Oncol., 1998; 5: 271-278
  Google Scholar
• 36. Henn V., Slupsky J.R., Gräfe M., Anagnostopoulos I., Förster R.,Müller-Berghaus G., Kroczek R.A.: CD40 ligand on activated plateletstriggers an inflammatory reaction of endothelial cells. Nature,1998; 391: 591-594
  Google Scholar
• 37. Hong K.H., Ryu J., Han K.H.: Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growthfactor-A. Blood, 2005; 105: 1405-1407
  Google Scholar
• 38. Hood J.D., Meininger C.J., Ziche M., Granger H.J.: VEGF upregulatesecNOS message, protein, and NO production in human endothelialcells. Am. J. Physiol., 1998; 274: H1054-H1058
  Google Scholar
• 39. Horiuchi T., Weller P.F.: Expression of vascular endothelialgrowth factor by human eosinophils: upregulation by granulocytemacrophage colony-stimulating factor and interleukin-5. Am. J.Respir. Cell Mol. Biol., 1997; 17: 70-77
  Google Scholar
• 40. Hornig C., Barleon B., Ahmad S., Vuorela P., Ahmed A., WeichH.A.: Release and complex formation of soluble VEGFR-1 from endothelialcells and biological fluids. Lab. Invest., 2000; 80: 443-454
  Google Scholar
• 41. Hornig C., Behn T., Bartsch W., Yayon A., Weich H.A.: Detectionand quantification of complexed and free soluble human vascularendothelial growth factor receptor-1 (sVEGFR-1) by ELISA. J. Immunol.Methods, 1999; 226: 169-177
  Google Scholar
• 42. Hoshino M., Nakamura Y., Hamid Q.A.: Gene expression of vascularendothelial growth factor and its receptors and angiogenesisin bronchial asthma. J. Allergy Clin. Immunol., 2001; 107: 1034-1038
  Google Scholar
• 43. Hoshino M., Takahashi M., Aoike N.: Expression of vascular endothelialgrowth factor, basic fibroblast growth factor, and angiogeninimmunoreactivity in asthmatic airways and its relationship toangiogenesis. J. Allergy Clin. Immunol., 2001; 107: 295-301
  Google Scholar
• 44. Iijima K., Yoshikawa N., Nakamura H.: Activation-induced expressionof vascular permeability factor by human peripheral T cells:a non-radioisotopic semiquantitative reverse transcription-polymerasechain reaction assay. J. Immunol. Methods, 1996; 196: 199-209
  Google Scholar
• 45. Iruela-Arispe M.L., Dvorak H.F.: Angiogenesis: a dynamic balanceof stimulators and inhibitors. Thromb. Haemost., 1997; 78: 672-677
  Google Scholar
• 46. Jelkmann W.: Pitfalls in the measurement of circulating vascularendothelial growth factor. Clin. Chem., 2001; 47: 617-623
  Google Scholar
• 47. Jozkowicz A., Cooke J.P., Guevara I., Huk I., Funovics P., PachingerO., Weidinger F., Dulak J.: Genetic augmentation of nitric oxide synthaseincreases the vascular generation of VEGF. Cardiovasc. Res.,2001; 51: 773-783
  Google Scholar
• 48. Kasperska-Zajac A., Nowakowski M., Rogala B.: Enhanced plateletactivation in patients with atopic eczema/dermatitis syndrome.Inflammation, 2004; 28: 299-302
  Google Scholar
• 49. Kasperska-Zajac A., Rogala B.: Markers of platelet activation inplasma of patients suffering from persistent allergic rhinitis withor without asthma symptoms. Clin. Exp. Allergy, 2005; 35: 1462-1465
  Google Scholar
• 50. Kasperska-Zajac A., Rogala B.: Platelet function in anaphylaxis.J. Investig. Allergol. Clin. Immunol., 2006; 16: 1-4
  Google Scholar
• 51. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., Koh G.Y.: Vascularendothelial growth factor expression of intercellular adhesionmolecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1),and E-selectin through nuclear factor-κB activation in endothelialcells. J. Biol. Chem., 2001; 276: 7614-7620
  Google Scholar
• 52. Kiriakidis S., Andreakos E., Monaco C., Foxwell B., FeldmannM., Paleolog E.: VEGF expression in human macrophages is NF-κBdependent:studies using adenoviruses expressing the endogenousNF-κB inhibitor IκBα and a kinase-defective form of the IκB kinase
  Google Scholar
• 53. Koczy-Baron E., Jochem J., Kasperska-Zajac A.: Increased plasmaconcentration of vascular endothelial growth factor in patients withatopic dermatitis and its relation to disease severity and plateletactivation. Inflamm. Res., 2012; 61: 1405-1409
  Google Scholar
• 54. Koehne P., Willam C., Strauss E., Schindler R., Eckardt K.U., BührerC.: Lack of hypoxic stimulation of VEGF secretion from neutrophilsand platelets. Am. J. Physiol. Heart Circ. Physiol., 2000; 279:H817-H824
  Google Scholar
• 55. Kunstfeld R., Hirakawa S., Hong Y.K., Schacht V., Lange-AsschenfeldtB., Velasco P., Lin C., Fiebiger E., Wei X., Wu Y., Hicklin D.,Bohlen P., Detmar M.: Induction of cutaneous delayed-type hypersensitivityreactions in VEGF-A transgenic mice results in chronicskin inflammation associated with persistent lymphatic hyperplasia.Blood, 2004; 104: 1048-1057
  Google Scholar
• 56. Lal B.K., Varma S., Pappas P.J., Hobson R.W. 2nd, Durán W.N.: VEGFincreases permeability of the endothelial cell monolayer by activationof PKB/akt, endothelial nitric-oxide synthase, and MAP kinasepathways. Microvasc. Res., 2001; 62: 252-262
  Google Scholar
• 57. Lee C.G., Link H., Baluk P., Homer R.J., Chapoval S., Bhandari V.,Kang M.J., Cohn L., Kim Y.K., McDonald D.M., Elias J.A.: Vascular endothelialgrowth factor (VEGF) induces remodeling and enhancesTH2-mediated sensitization and inflammation in the lung. Nat. Med.,2004; 10: 1095-1103
  Google Scholar
• 58. Lee K.S., Kim S.R., Park H.S., Jin G.Y., Lee Y.C.: Cysteinyl leukotrienereceptor antagonist regulates vascular permeability by reducingvascular endothelial growth factor expression. J. Allergy Clin.Immunol., 2004; 114: 1093-1099
  Google Scholar
• 59. Lee K.S., Min K.H., Kim S.R., Park S.J., Park H.S., Jin G.Y., LeeY.C.: Vascular endothelial growth factor modulates matrix metalloproteinase-9expression in asthma. Am. J. Respir. Crit. Care Med.,2006; 174: 161-170
  Google Scholar
• 60. Maeno N., Takei S., Imanaka H., Takasaki I., Kitajima I., MaruyamaI., Matsuo K., Miyata K.: Increased circulating vascular endothelialgrowth factor is correlated with disease activity in polyarticularjuvenile rheumatoid arthritis. J. Rheumatol., 1999; 26: 2244-2248
  Google Scholar
• 61. Makinde T., Murphy R.F., Agrawal D.K.: Immunomodulatory roleof vascular endothelial growth factor and angiopoietin-1 in airwayremodeling. Curr. Mol. Med., 2006; 6: 831-841
  Google Scholar
• 62. Matsushita K., Yamakuchi M., Morrell C.N., Ozaki M., O’RourkeB., Irani K., Lowenstein C.J.: Vascular endothelial growth factor regulationof Weibel-Palade-body exocytosis. Blood, 2005; 105: 207-214
  Google Scholar
• 63. Mechtcheriakova D., Wlachos A., Holzmüller H., Binder B.R.,Hofer E.: Vascular endothelial cell growth factor-induced tissuefactor expression in endothelial cells is mediated by EGR-1. Blood,1999; 93: 3811-3823
  Google Scholar
• 64. Melter M., Reinders M.E., Sho M., Pal S., Geehan C., Denton M.D.,Mukhopadhyay D., Briscoe D.M.: Ligation of CD40 induces the expressionof vascular endothelial growth factor by endothelial cellsand monocytes and promotes angiogenesis in vivo. Blood, 2000; 96:3801-3808
  Google Scholar
• 65. Mimura K., Kono K., Takahashi A., Kawaguchi Y., Fujii H.: Vascularendothelial growth factor inhibits the function of human maturedendritic cells mediated by VEGF receptor-2. Cancer Immunol. Immunother.,2007; 56: 761-770
  Google Scholar
• 66. Monaco C., Andreakos E., Kiriakidis S., Feldmann M., Paleolog E.:T-cell-mediated signalling in immune, inflammatory and angiogenicprocesses: the cascade of events leading to inflammatory diseases.Curr. Drug Targets Inflamm. Allergy, 2004; 3: 35-42
  Google Scholar
• 67. Mor F., Quintana F.J., Cohen I.R.: Angiogenesis-inflammationcross-talk: vascular endothelial growth factor is secreted by activatedT cells and induces Th1 polarization. J. Immunol., 2004; 172:4618-4623
  Google Scholar
• 68. Nakasone T., Hanashiro K., Nakamura M., Sunakawa H., KosugiT.: Mast cell-derived VEGF enhances the passage of IgE FE-3 throughthe rat aortic endothelial cell monolayer. Int. Arch. Allergy Immunol.,2002; 129: 76-85
  Google Scholar
• 69. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z.: Vascularendothelial growth factor (VEGF) and its receptors. FASEB J., 1999;13: 9-22
  Google Scholar
• 70. Palacio S., Schmitt D., Viac J.: Contact allergens and sodium laurylsulphate upregulate vascular endothelial growth factor in normalkeratinocytes. Br. J. Dermatol., 1997; 137: 540-544
  Google Scholar
• 71. Park H.W., Lee J.E., Shin E.S., Lee J.Y., Bahn J.W., Oh H.B., Oh S.Y.,Cho S.H., Moon H.B., Min K.U., Elias J.A., Kim Y.Y., Kim Y.K.: Associationbetween genetic variations of vascular endothelial growth factorreceptor 2 and atopy in the Korean population. J. Allergy Clin.Immunol., 2006; 117: 774-779
  Google Scholar
• 72. Powroźnik B., Kubowicz P., Pękala E.: Przeciwciała monoklonalnew terapii celowanej. Postępy Hig. Med. Dośw., 2012; 66: 663-673
  Google Scholar
• 73. Ratajska A., Jankowska-Steifer E., Czarnowska E., Flaht A., Radomska-LeśniewskaD.: Morfogeneza, budowa i właściwości naczyńlimfatycznych. Postępy Hig. Med. Dośw., 2012; 66: 901-912
  Google Scholar
• 74. Regulska K., Stanisz B., Regulski M.: Indywidualizacja terapiiprzeciwnowotworowej; molekularne uwarunkowania mechanizmówdziałania nowoczesnych leków onkologicznych. Postępy Hig. Med.Dośw., 2012; 66: 855-867
  Google Scholar
• 75. Reinders M.E., Sho M., Izawa A., Wang P., Mukhopadhyay D.,Koss K.E., Geehan C.S., Luster A.D., Sayegh M.H., Briscoe D.M.: Proinflammatoryfunctions of vascular endothelial growth factor inalloimmunity. J. Clin. Invest., 2003; 112: 1655-1665
  Google Scholar
• 76. Reinders M.E., Sho M., Robertson S.W., Geehan C.S., BriscoeD.M.: Proangiogenic function of CD40 ligand-CD40 interactions. J.Immunol., 2003; 171: 1534-1541
  Google Scholar
• 77. Riboldi E., Musso T., Moroni E., Urbinati C., Bernasconi S., RusnatiM., Adorini L., Presta M., Sozzani S.: Cutting edge: proangiogenicproperties of alternatively activated dendritic cells. J. Immunol.,2005; 175: 2788-2792
  Google Scholar
• 78. Roberts W.G., Palade G.E.: Increased microvascular permeabilityand endothelial fenestration induced by vascular endothelial growthfactor. J. Cell Sci., 1995; 108: 2369-2379
  Google Scholar
• 79. Roeckl W., Hecht D., Sztajer H., Waltenberger J., Yayon A., WeichH.A.: Differential binding characteristics and cellular inhibitionby soluble VEGF receptors 1 and 2. Exp. Cell Res., 1998; 241: 161-170
  Google Scholar
• 80. Ruohola J.K., Valve E.M., Karkkainen M.J., Joukov V., Alitalo K.,Härkönen P.L.: Vascular endothelial growth factors are differentiallyregulated by steroid hormones and antiestrogens in breast cancercells. Mol. Cell. Endocrinol., 1999; 149: 29-40
  Google Scholar
• 81. Ryu S., Lee J.H., Kim S.I.: IL-17 increased the production of vascularendothelial growth factor in rheumatoid arthritis synoviocytes.Clin. Rheumatol., 2006; 25: 16-20
  Google Scholar
• 82. Salven P., Hattori K., Heissig B., Rafii S.: Interleukin-1α (IL-1α)promotes angiogenesis in vivo via VEGFR-2 pathway by inducinginflammatory cell VEGF synthesis and secretion. FASEB J., 2002;16: 1471-1473
  Google Scholar
• 83. Scalia R., Booth G., Lefer D.J.: Vascular endothelial growth factorattenuates leukocyte-endothelium interaction during acute endothelialdysfunction: essential role of endothelium-derived nitricoxide. FASEB J., 1999; 13: 1039-1046
  Google Scholar
• 84. Schmeisser A., Christoph M., Augstein A., Marquetant R., KasperM., Braun-Dullaeus R.C., Strasser R.H.: Apoptosis of human macrophagesby Flt-4 signaling: implications for atherosclerotic plaquepathology. Cardiovasc. Res., 2006; 71: 774-784
  Google Scholar
• 85. Seetharam L., Gotoh N., Maru Y., Neufeld G., Yamaguchi S.,Shibuya M.: A unique signal transduction from FLT tyrosine kinase,a receptor for vascular endothelial growth factor VEGF. Oncogene,1995; 10: 135-147
  Google Scholar
• 86. Senger D.R., Connolly D.T., Van de Water L., Feder J., Dvorak H.F.: Purificationand NH2-terminal amino acid sequence of guinea pig tumorsecretedvascular permeability factor. Cancer Res., 1990; 50: 1774-1778
  Google Scholar
• 87. Senger D.R, Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S.,Dvorak H.F.: Tumor cells secrete a vascular permeability factor thatpromotes accumulation of ascites fluid. Science, 1983; 219: 983-985
  Google Scholar
• 88. Senger D.R., Van de Water L., Brown L.F., Nagy J.A., Yeo K.T.,Yeo T.K., Berse B., Jackman R.W., Dvorak A.M., Dvorak H.F.: Vascularpermeability factor (VPF, VEGF) in tumor biology. Cancer MetastasisRev., 1993; 12: 303-324
  Google Scholar
• 89. Shibuya M.: Structure and dual function of vascular endothelialgrowth factor receptor-1 (Flt-1). Int. J. Biochem. Cell Biol., 2001;33: 409-420
  Google Scholar
• 90. Shibuya M.: Structure and function of VEGF/VEGF-receptorsystem involved in angiogenesis. Cell Struct. Funct., 2001; 26: 25-35
  Google Scholar
• 91. Shibuya M.: Vascular endothelial growth factor (VEGF)-Receptor2:its biological functions, major signaling pathway, and specificligand VEGF-E. Endothelium, 2006; 13: 63-69
  Google Scholar
• 92. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., MatsushimeH., Sato M.: Nucleotide sequence and expression of a novelhuman receptor-type tyrosine kinase gene (flt) closely related to thefms family. Oncogene, 1990; 5: 519-524
  Google Scholar
• 93. Simcock D.E., Kanabar V., Clarke G.W., O’Connor B.J., Lee T.H.,Hirst S.J.: Proangiogenic activity in bronchoalveolar lavage fluidfrom patients with asthma. Am. J. Respir. Crit. Care Med., 2007; 176:146-153
  Google Scholar
• 94. Sirois M.G., Edelman E.R.: VEGF effect on vascular permeabilityis mediated by synthesis of platelet-activating factor. Am. J. Physiol.,1997; 272: H2746-H2756
  Google Scholar
• 95. Smith J.R., Lanier V.B., Braziel R.M., Falkenhagen K.M., WhiteC., Rosenbaum J.T.: Expression of vascular endothelial growth factorand its receptors in rosacea. Br. J. Ophthalmol., 2007; 91: 226-229
  Google Scholar
• 96. Szala S., Jarosz M.: Nowotworowe naczynia krwionośne. PostępyHig. Med. Dośw., 2011; 65: 437-446
  Google Scholar
• 97. Taichman N.S., Young S., Cruchley A.T., Taylor P., Paleolog E.:Human neutrophils secrete vascular endothelial growth factor. J.Leukoc. Biol., 1997; 62: 397-400
  Google Scholar
• 98. Takahashi H., Shibuya M.: The vascular endothelial growth factor(VEGF)/VEGF receptor system and its role under physiologicaland pathological conditions. Clin. Sci., 2005; 109: 227-241
  Google Scholar
• 99. Tchaikovski V., Fellbrich G., Waltenberger J.: The molecular basisof VEGFR-1 signal transduction pathways in primary human monocytes.Arterioscler. Thromb. Vasc. Biol., 2008; 28: 322-328
  Google Scholar
• 100. Telo P., Breviario F., Huber P., Panzeri C., Dejana E.: Identificationof a novel cadherin (vascular endothelial cadherin-2) locatedat intercellular junctions in endothelial cells. J. Biol. Chem., 1998;273: 17565-17572
  Google Scholar
• 101. Terman B.I., Dougher-Vermazen M., Carrion M.E., DimitrovD., Armellino D.C., Gospodarowicz D., Böhlen P.: Identification ofthe KDR tyrosine kinase as a receptor for vascular endothelial cellgrowth factor. Biochem. Biophys. Res. Commun., 1992; 187: 1579-1586
  Google Scholar
• 102. Topaloglu R., Sungur A., Baskin E., Besbas N., Saatci U., BakkalogluA.: Vascular endothelial growth factor in Henoch-Schonleinpurpura. J. Rheumatol., 2001; 28: 2269-2273
  Google Scholar
• 103. Trompezinski S., Berthier-Vergnes O., Denis A., Schmitt D., ViacJ.: Comparative expression of vascular endothelial growth factorfamily members, VEGF-B, -C and -D, by normal human keratinocytesand fibroblasts. Exp. Dermatol., 2004; 13: 98-105
  Google Scholar
• 104. Trompezinski S., Denis A., Schmitt D., Viac J.: Comparative effectsof polyphenols from green tea (EGCG) and soybean (genistein)on VEGF and IL-8 release from normal human keratinocytes stimulatedwith the proinflammatory cytokine TNFα. Arch. Dermatol.Res., 2003; 295: 112-116
  Google Scholar
• 105. Trompezinski S., Denis A., Vinche A., Schmitt D., Viac J.: IL-4 andinterferon-γ differentially modulate vascular endothelial growthfactor release from normal human keratinocytes and fibroblasts.Exp. Dermatol., 2002; 11: 224-231
  Google Scholar
• 106. Trompezinski S., Pernet I., Schmitt D., Viac J.: UV radiationand prostaglandin E2 up-regulate vascular endothelial growth factor(VEGF) in cultured human fibroblasts. Inflamm. Res., 2001; 50:422-427
  Google Scholar
• 107. Underiner T.L., Ruggeri B., Gingrich D.E.: Development of vascularendothelial growth factor receptor (VEGFR) kinase inhibitorsas anti-angiogenic agents in cancer therapy. Curr. Med. Chem.,2004; 11: 731-745
  Google Scholar
• 108. Wakita H., Sakamoto T., Tokura Y., Takigawa M.: E-selectin andvascular cell adhesion molecule-1 as critical adhesion molecules forinfiltration of T lymphocytes and eosinophils in atopic dermatitis.J. Cutan. Pathol., 1994; 21: 33-39
  Google Scholar
• 109. Watanabe H., Mamelak A.J., Wang B., Howell B.G., Freed I., EscheC., Nakayama M., Nagasaki G., Hicklin D.J., Kerbel R.S., Sauder D.N.: Anti-vascularendothelial growth factor receptor-2 (Flk-1/KDR) antibodysuppresses contact hypersensitivity. Exp. Dermatol., 2004; 13: 671-681
  Google Scholar
• 110. Weninger W., Rendl M., Mildner M., Tschachler E.: Retinoidsdownregulate vascular endothelial growth factor/vascular permeabilityfactor production by normal human keratinocytes. J. Invest.Dermatol., 1998; 111: 907-911
  Google Scholar
• 111. Xia Y.P., Li B., Hylton D., Detmar M., Yancopoulos G.D., RudgeJ.S.: Transgenic delivery of VEGF to mouse skin leads to an inflammatorycondition resembling human psoriasis. Blood, 2003; 102: 161-168
  Google Scholar
• 112. Yamada T., Sawatsubashi M., Yakushiji H., Itoh Y., Edakuni G.,Mori M., Robert L., Miyazaki K.: Localization of vascular endothelialgrowth factor in synovial membrane mast cells: examinationwith „multi-labelling subtraction immunostaining”. Virchows Arch.,1998; 433: 567-570
  Google Scholar
• 113. Yamaoka-Tojo M., Tojo T, Kim H.W., Hilenski L., Patrushev N.A.,Zhang L., Fukai T., Ushio-Fukai M.: IQGAP1 mediates VE-cadherinbasedcell-cell contacts and VEGF signaling at adherence junctionslinked to angiogenesis. Arterioscler. Thromb. Vasc. Biol., 2006; 26:1991-1997
  Google Scholar
• 114. Yano K., Liaw P.C., Mullington J.M., Shih S.C., Okada H., BodyakN., Kang P.M., Toltl L., Belikoff B., Buras J., Simms B.T., Mizgerd J.P.,Carmeliet P., Karumanchi S.A., Aird W.C.: Vascular endothelialgrowth factor is an important determinant of sepsis morbidity andmortality. J. Exp. Med., 2006; 203: 1447-1458
  Google Scholar
• 115. Zhang Y., Matsuo H., Morita E.: Increased production of vascularendothelial growth factor in the lesions of atopic dermatitis.Arch. Dermatol. Res., 2006; 297: 425-429
  Google Scholar
• 116. Zittermann S.I., Issekutz A.C.: Endothelial growth factors VEGFand bFGF differentially enhance monocyte and neutrophil recruitmentto inflammation. J. Leukoc. Biol., 2006; 80: 247-257
  Google Scholar

Full text